Wave Life Sciences Ltd (WVE) Options

Are these RNA editing indications even necessary with regular RNAI-SIRNA drug pipeline of 450 drugs seems like most of these editing drugs like gene editing are all flops companies not sure about RNA Editing when companies like ALNY and Novartis have the goods to make good old fashion Sirna drugs

$WVE

https://fintel.io/i/m28-capital-management-lp


Top Increases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.


WVE / Wave Life Sciences Ltd. 5.66 70.07 68.7941 13.2486
TGTX / TG Therapeutics, Inc. 0.16 4.86 4.7756 0.6221
PRQR / ProQR Therapeutics N.V. 1.02 2.70 2.6525 0.6136
SWTX / SpringWorks Therapeutics, Inc. 0.11 3.99 3.9161 0.0293


almost 70% of M28 Capital is in WVE that is lead and advised John Maraganore, PhD. Alnylam Pharmaceuticals. Cambridge, MA. Brook ... M28 Capital Management.

$WVE

Will wait for buyout on my $6.80 average here.

$WVE

RNAI stocks are going to be the biggest driver in biotech in the through 2030 WAVE and PRQR
These could be the next ALNY
450 drugs in the pipeline worldwide for RNAI drugs.

$WVE

Gotta love their business.

If their RNA model works, it could have fantastic results for humanity.

Finally,,,,,,,, "they" will water them all and things will get going. RNA in genetic diseases....

beautiful....

Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

WVE Can't wait for the Phase 1 Obesity indication to commence later this year or early 2025 thats the icing on the cake.

$WVE

can you say breakout?

why claim this afterwards? Pointless

Poetry in Motion!

$WVE

Solid looking for more!

Glad I doubled up last week!

$WVE

wowser there it is

Dystrophin results from a pre-specified analysis of ambulatory boys showed:
Mean absolute muscle content-adjusted dystrophin expression was 9.0% (range: 4.6-13.9%) and mean absolute unadjusted dystrophin expression was 5.5% of normal (range: 3.3-8.3%), as measured by Western Blot.
[...]
89% of ambulatory participants achieved muscle content-adjusted dystrophin levels of at least 5%.

WVE under $7

WVE under $10

one of the singaporean companies that does not look like a scam but rather like singaporean excellence.

WVE under $10

WVE new 52 week high

WVE...BEAUTIFUL WEEKLY

WVE...BIO MONSTER SETTING UP

Big clinical news coming shortly

Company reporting big news next week. Stay tuned!

WVE stretched out this morning!

WAVE LIFE SCIENCES LTD
$5.24 +$0.20 (+3.97%)

WVE is a real stock!

https://stockcharts.com/h-sc/ui?s=WVE